Dong-A Socio Holdings Logo (Photo by Dong-A Socio Holdings)

Dong-A Socio Holdings Logo (Photo by Dong-A Socio Holdings)

View original image

[Asia Economy Reporter Chunhee Lee] Dong-A Socio Holdings recorded sales of 269.4 billion KRW and operating profit of 22.4 billion KRW in the third quarter of this year.


Dong-A Socio Holdings announced on the 2nd that its consolidated operating (preliminary) results for the third quarter were sales of 269.437 billion KRW, operating profit of 22.432 billion KRW, and net profit of 25.541 billion KRW. Compared to the same period last year, sales and operating profit increased by 13.0% and 11.4%, respectively. The company explained, "Sales and operating profit increased thanks to the balanced growth of major subsidiaries." However, net profit decreased by 59.3%.


Looking at each subsidiary, Dong-A Pharmaceutical, a company specializing in over-the-counter (OTC) drugs, posted sales of 151.5 billion KRW, up 27.8% year-on-year, with increased sales across all sectors including Bacchus, OTC drugs, and the health and lifestyle business. Operating profit also rose 63% to 27.9 billion KRW.


STGen Bio, a biopharmaceutical company, recorded sales of 7 billion KRW, a 1.7% increase compared to the same period last year. However, operating profit turned to a loss of 3.2 billion KRW.



Logistics specialist Yongma Logistics posted sales of 90.5 billion KRW and operating profit of 1.7 billion KRW. Dongchunsu, a bottled water specialist, recorded sales of 9 billion KRW and operating profit of 200 million KRW.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing